Vyvgart (efgartigimod alfa)

pCPA File Number: 22530

Negotiation Status:

Concluded with an LOI

Indication(s):

Generalized myasthenia gravis (gMG)

Sponsor/Manufacturer:

Argenx Canada Inc.

CDA-AMC Project Number:

SR0782-000

pCPA Engagement Letter Issued:

2024-05-27

Negotiation Process Concluded:

2024-12-13